Rep. Robert Bresnahan, Jr. Purchases Shares of CME Group Inc. (NASDAQ:CME)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on April 8th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/17/2025.
• Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/11/2025.
• Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/10/2025.
• Sold $1,001 - $15,000 in shares of DexCom NASDAQ: DXCM on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Invesco NYSE: IVZ on 4/8/2025.
• Sold $1,001 - $15,000 in shares of Generac NYSE: GNRC on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Occidental Petroleum NYSE: OXY on 4/8/2025.
• Sold $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 4/8/2025.
• Sold $1,001 - $15,000 in shares of QUALCOMM NASDAQ: QCOM on 4/8/2025.

CME Group Price Performance

CME Group stock traded up $2.36 during mid-day trading on Friday, reaching $284.35. 953,386 shares of the company's stock traded hands, compared to its average volume of 2,153,918. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a 50 day moving average of $264.47 and a two-hundred day moving average of $245.55. The company has a market cap of $102.47 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm earned $2.50 EPS. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. CME Group's dividend payout ratio is currently 50.30%.

Analyst Ratings Changes

Several research analysts have commented on the stock. JPMorgan Chase & Co. dropped their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Barclays upped their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. UBS Group upped their target price on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Finally, Oppenheimer increased their price target on CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a report on Friday, April 11th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $256.80.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Wayfinding Financial LLC acquired a new stake in shares of CME Group during the first quarter worth $25,000. SJS Investment Consulting Inc. lifted its position in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after acquiring an additional 97 shares during the period. Cornerstone Planning Group LLC grew its stake in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. New Age Alpha Advisors LLC raised its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC lifted its holdings in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other news, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider now owns 8,336 shares of the company's stock, valued at $2,339,164.96. The trade was a 35.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,726 shares of company stock worth $8,975,813 over the last quarter. Insiders own 0.30% of the company's stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.